<?xml version="1.0" encoding="UTF-8"?>
<p>In patients who are HBsAg-positive, anti-HBV prophylaxis is recommended independent of serum HBV DNA, and HBV DNA and ALT should be monitored every 3 to 6 months during, and for at least 12 months after anti-HBV prophylaxis, because many HBV reactivations develop after antiviral therapy has been discontinued [
 <xref rid="b113-ir-2019-09155" ref-type="bibr">113</xref>-
 <xref rid="b117-ir-2019-09155" ref-type="bibr">117</xref>].
</p>
